PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.56%
Some net income increase while CNQ is negative at -45.98%. John Neff would see a short-term edge over the struggling competitor.
-3.78%
Negative yoy D&A while CNQ is 115.20%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-355.68%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
10.87%
Less SBC growth vs. CNQ's 8075.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-116.13%
Both reduce yoy usage, with CNQ at -49.51%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-88.00%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
141.64%
Inventory growth of 141.64% while CNQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
80.58%
AP growth of 80.58% while CNQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-116.13%
Both reduce yoy usage, with CNQ at -49.51%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-4.71%
Both negative yoy, with CNQ at -157.14%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-9.04%
Both yoy CFO lines are negative, with CNQ at -25.48%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
29.94%
Some CapEx rise while CNQ is negative at -8.13%. John Neff would see competitor possibly building capacity while we hold back expansions.
-219.25%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-38.24%
Both yoy lines negative, with CNQ at -1366.67%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-123.86%
Both yoy lines negative, with CNQ at -11.78%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
99.81%
We repay more while CNQ is negative at -272.63%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
42.15%
Buyback growth at 50-75% of CNQ's 57.05%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.